| Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitment AW Greene, K Grenier, MA Aguileta, S Muise, R Farazifard, ME Haque, ... EMBO reports 13 (4), 378-385, 2012 | 780 | 2012 |
| Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling Y Yang, S Gehrke, ME Haque, Y Imai, J Kosek, L Yang, MF Beal, ... Proceedings of the National Academy of Sciences 102 (38), 13670-13675, 2005 | 463 | 2005 |
| Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP ME Haque, KJ Thomas, C D'Souza, S Callaghan, T Kitada, RS Slack, ... Proceedings of the National Academy of Sciences 105 (5), 1716-1721, 2008 | 309 | 2008 |
| Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease D Qu, J Rashidian, MP Mount, H Aleyasin, M Parsanejad, A Lira, E Haque, ... Neuron 55 (1), 37-52, 2007 | 284 | 2007 |
| Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in … H Javed, S Azimullah, ME Haque, SK Ojha Frontiers in neuroscience 10, 321, 2016 | 214 | 2016 |
| Leucine-rich repeat kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson's disease K Venderova, G Kabbach, E Abdel-Messih, Y Zhang, RJ Parks, Y Imai, ... Human molecular genetics 18 (22), 4390-4404, 2009 | 207 | 2009 |
| β-Caryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation, and salvages dopaminergic neurons in a rat model of Parkinson disease S Ojha, H Javed, S Azimullah, ME Haque Molecular and cellular biochemistry 418, 59-70, 2016 | 188 | 2016 |
| Apoptosis-inducing neurotoxicity of dopamine and its metabolites via reactive quinone generation in neuroblastoma cells ME Haque, M Asanuma, Y Higashi, I Miyazaki, K Tanaka, N Ogawa Biochimica et Biophysica Acta (BBA)-General Subjects 1619 (1), 39-52, 2003 | 185 | 2003 |
| Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease S Ojha, H Javed, S Azimullah, SB Abul Khair, ME Haque Drug design, development and therapy, 5499-5510, 2015 | 179 | 2015 |
| Structure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicity MT Ardah, KE Paleologou, G Lv, SB Abul Khair, AS Kazim, ST Minhas, ... Frontiers in aging neuroscience 6, 197, 2014 | 136 | 2014 |
| Neuroprotective effect of nerolidol against neuroinflammation and oxidative stress induced by rotenone H Javed, S Azimullah, SB Abul Khair, S Ojha, ME Haque BMC neuroscience 17, 1-12, 2016 | 135 | 2016 |
| The role of Cdk5-mediated apurinic/apyrimidinic endonuclease 1 phosphorylation in neuronal death E Huang, D Qu, Y Zhang, K Venderova, ME Haque, MWC Rousseaux, ... Nature cell biology 12 (6), 563-571, 2010 | 129 | 2010 |
| Longitudinal changes in CSF alpha‐synuclein species reflect Parkinson's disease progression NK Majbour, NN Vaikath, P Eusebi, D Chiasserini, M Ardah, S Varghese, ... Movement Disorders 31 (10), 1535-1542, 2016 | 127 | 2016 |
| Inactivation of Pink1 gene in vivo sensitizes dopamine-producing neurons to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) and can be rescued by autosomal recessive … ME Haque, MP Mount, F Safarpour, E Abdel-Messih, S Callaghan, ... Journal of Biological Chemistry 287 (27), 23162-23170, 2012 | 105 | 2012 |
| Glycyrrhizic acid attenuates neuroinflammation and oxidative stress in rotenone model of Parkinson’s disease S Ojha, H Javed, S Azimullah, SB Abul Khair, ME Haque Neurotoxicity research 29, 275-287, 2016 | 94 | 2016 |
| Molecular mechanism in activation of glutathione system by ropinirole, a selective dopamine D2 agonist K Tanaka, I Miyazaki, N Fujita, ME Haque, M Asanuma, N Ogawa Neurochemical research 26, 31-36, 2001 | 67 | 2001 |
| Thymoquinone prevents neurodegeneration against MPTP in vivo and modulates α-synuclein aggregation in vitro MT Ardah, MM Merghani, ME Haque Neurochemistry international 128, 115-126, 2019 | 52 | 2019 |
| Development of nonviral vectors targeting the brain as a therapeutic approach for Parkinson's disease and other brain disorders H Javed, SA Menon, KM Al-Mansoori, A Al-Wandi, NK Majbour, MT Ardah, ... Molecular Therapy 24 (4), 746-758, 2016 | 51 | 2016 |
| Ellagic acid prevents dopamine neuron degeneration from oxidative stress and neuroinflammation in MPTP model of Parkinson’s disease MT Ardah, G Bharathan, T Kitada, ME Haque Biomolecules 10 (11), 1519, 2020 | 49 | 2020 |
| Paradoxical mitophagy regulation by PINK1 and TUFm J Lin, K Chen, W Chen, Y Yao, S Ni, M Ye, G Zhuang, M Hu, J Gao, C Gao, ... Molecular cell 80 (4), 607-620. e12, 2020 | 48 | 2020 |
